INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03696 INSILICO

Closed 02-12 16:08:08

73.650

+0.450

+0.61%

High78.100	Low71.500	Vol1.50M
Open74.500	D1 Closing73.200	Amplitude9.02%
Mkt Cap42.10B	Tradable Cap42.10B	Total Shares571.62M
T/O111.36M	T/O Rate0.26%	Tradable Shares571.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":73.65,"timestamp":1770883688138,"preClose":73.2,"halted":0,"volume":1498990,"delay":0,"changeRate":0.006147540983606596,"floatShares":571622000,"shares":571622000,"eps":-0.238,"marketStatus":"Closed","change":0.45,"latestTime":"02-12 16:08:08","open":74.5,"high":78.1,"low":71.5,"amount":111355381,"amplitude":0.090164,"askPrice":74,"askSize":2500,"bidPrice":73.65,"bidSize":3500,"shortable":0,"etf":0,"ttmEps":-0.624,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770946200000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":73.2,"openAndCloseTimeList":[[1770859800000,1770868800000],[1770872400000,1770883200000]],"volumeRatio":0.650786,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696/tweets","defaultTab":"tweets","newsList":[{"id":"2610696513","title":"BUZZ-InSilico hits fresh high on partnership deal with China Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2610696513","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610696513?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:17","pubTimestamp":1770689824,"startTime":"0","endTime":"0","summary":"BUZZ-InSilico hits fresh high on partnership deal with China Medical.** Shares of InSilico Medicine Cayman TopCo 3696.HK jump 9.9% to HK$73.8, a fresh high since their debut on December 30, 2025** Stock on track for biggest daily gain since February 3; on track for second session of rise** InSilico says it has entered into a strategic partnership with China Medical System 0867.HK on innovative drug development in the fields of central nervous system and autoimmune diseases** Insilico says the two parties will jointly advance the co-development of no fewer than two R&D programs** The company is expected to receive R&D funding support of up to several tens of millions of Hong Kong dollars for each program** Shares of China Medical System slip 2% ** Insilico stock has soared 202% from the HK$24.05 IPO price in nearly 6 weeks** YTD, Insilico shares up 92.5%, Hang Seng Biotech Index .HSBIO up 11.3%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL1N3Z601U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","IE00BGHQDM52.EUR","SG9999015945.SGD","00867","IE00BMCWC346.EUR","BK1191","IE00BVYPNP33.GBP","03696","SG9999004220.SGD","IE00BVYPNQ40.USD","BK1141","IE00BYV24P56.USD","LU2488822045.USD","SG9999015986.USD","SG9999015978.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2610693787","title":"Insilico Medicine Enters Drug Development Partnership With China Medical System","url":"https://stock-news.laohu8.com/highlight/detail?id=2610693787","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610693787?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:38","pubTimestamp":1770687485,"startTime":"0","endTime":"0","summary":"Insilico Medicine  said it entered a drug development partnership with China Medical System , according to a Hong Kong bourse filing Tuesday.Under the agreement, the two sides will collaborate to co-develop at least two drugs.Insilico Medicine is expected to receive R&D funding support of up to \"several tens of millions of HKD\" for each program.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999015952.SGD","03696","IE00BVYPNQ40.USD","00867","8A8.SI","BK1593","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","BK1191","IE00BYV24P56.USD","LU2488822045.USD","SG9999004220.SGD","SG9999015945.SGD","SG9999015978.USD","SG9999015986.USD","BK1141","BK6079","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"1185193421","title":"InSilico Medicine (3696.HK) and CMS (867.HK) Announce AI-Focused Drug Development Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1185193421","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185193421?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:21","pubTimestamp":1770682904,"startTime":"0","endTime":"0","summary":"InSilico Medicine (“the Company”) and China Medical System Holdings Limited (“CMS”) have entered a strategic partnership to pursue AI-driven drug development projects in the fields of central nervous...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":0},{"id":"1106267413","title":"Insilico Partners with CMS on Multi-Million-Dollar AI-Driven Drug Development for CNS and Autoimmune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=1106267413","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106267413?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:20","pubTimestamp":1770682819,"startTime":"0","endTime":"0","summary":"Insilico (03696) has announced that the group has entered into a strategic drug development collaboration with CMS. Under this partnership, the two companies will engage in a series of AI-enabled...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE00BVYPNQ40.USD","03696","BK1593","LU2488822045.USD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","BK1191","IE00BMCWC346.EUR","SG9999004220.SGD","SG9999015952.SGD","SG9999015986.USD","BK1141","00867","SG9999015945.SGD","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2610667618","title":"Insilico Medicine Cayman Topco startet Milliarden-Kooperation mit CMS zur Entwicklung von Medikamenten für das zentrale Nervensystem und Autoimmunerkrankungen","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667618","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667618?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:01","pubTimestamp":1770681703,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDLbDr1GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1593","SG9999004220.SGD","00867","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","IE00BYV24P56.USD","LU2488822045.USD","03696","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999015978.USD","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015945.SGD","BK1191"],"gpt_icon":0},{"id":"2610667696","title":"Insilico Medicine Cayman Topco - Deal to Collaborate Across Multiple Projects in Fields of Central Nervous System, Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667696","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667696?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681652,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51DE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2610667693","title":"Insilico Medicine Cayman Topco - Also Expected to Receive R+D Funding Support of up to Several Tens of Millions of HKD for Each Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667693?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51DE:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2610633667","title":"Insilico Medicine Cayman Topco - Insilico Medicine and CMS Enter Into Drug Development Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2610633667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610633667?lang=en_us&edition=fundamental","pubTime":"2026-02-10 08:00","pubTimestamp":1770681652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z51DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2609595962","title":"Insilico Medicine ernennt Halle Zhang zur Vizepräsidentin für klinische Entwicklung in der Onkologie","url":"https://stock-news.laohu8.com/highlight/detail?id=2609595962","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609595962?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382853,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire  on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL74yyKb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2609955175","title":"Insilico Medicine Appoints Halle Zhang, Phd (Med), as Vice President, Clinical Development - Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2609955175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609955175?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:00","pubTimestamp":1770382801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nTUA5C2TQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"2609308878","title":"Insilico Medicine nominiert ISM5059 als neuen NLRP3-Hemmer für Entzündungstherapien","url":"https://stock-news.laohu8.com/highlight/detail?id=2609308878","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609308878?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:01","pubTimestamp":1770296515,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL2fYx8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2609230886","title":"Insilico Medicine Nominates ISM5059, the Peripheral-Restricted Nlrp3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2609230886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609230886?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:01","pubTimestamp":1770296514,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z10QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03696"],"gpt_icon":0},{"id":"1160885073","title":"InSilico Medicine Cayman TopCo (03696) Announces Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1160885073","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160885073?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:00","pubTimestamp":1770282002,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman TopCo (03696) maintained an authorized share capital of USD 635, comprising 1,270,000,000 ordinary shares at a par value of USD 0.0000005 each. As of January 31, 2026, the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"gpt_icon":0},{"id":"2608872884","title":"Insilico Medicine Receives USD 5Million Milestone Payment From Menarini Group Following First-in-Human (Fih) Achievement for Men2501","url":"https://stock-news.laohu8.com/highlight/detail?id=2608872884","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608872884?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:01","pubTimestamp":1770127260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"32bc88debe3c17bc57e22a6f6b3dcca5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA1HP86V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"gpt_icon":0},{"id":"1172811044","title":"Southwest Securities Initiates Coverage on INSILICO (03696) with Positive Outlook, Anticipates Innovation Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=1172811044","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172811044?lang=en_us&edition=fundamental","pubTime":"2026-02-03 16:28","pubTimestamp":1770107321,"startTime":"0","endTime":"0","summary":"Southwest Securities has released a research report forecasting INSILICO's (03696) revenue for 2025-2027 to be $59 million, $155 million, and $202 million, respectively, with corresponding...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","600369","BK1141","BK0012","BK0183","BK0188","BK0028","BK0276"],"gpt_icon":0},{"id":"2608882055","title":"Insilico Medicine Advances AI Drug Discovery Model With New Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2608882055","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608882055?lang=en_us&edition=fundamental","pubTime":"2026-02-03 15:17","pubTimestamp":1770103069,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo (SEHK:3696) has secured a partnership with Qilu Pharmaceutical focused on cardiometabolic disease drug candidates.\nThe company received FDA IND clearance for a novel NLRP3 inhibitor, ISM8969, targeting Parkinson's Disease.\nInsilico launched its Science MMAI Gym to make its AI tools available to pharma R&D partners.\nA global co development agreement for ISM8969 was signed with Hygtia Therapeutics, expanding the candidate's reach.\n\nFor investors tracking AI...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-advances-ai-drug-discovery-model-with-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-advances-ai-drug-discovery-model-with-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","BK4543","BK1141","BK4587","BK4551","BK4528","BK4023","03696"],"gpt_icon":1},{"id":"2608984651","title":"BUZZ-Insilico hits fresh high on milestone payment from Menarini Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2608984651","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608984651?lang=en_us&edition=fundamental","pubTime":"2026-02-03 12:35","pubTimestamp":1770093322,"startTime":"0","endTime":"0","summary":"BUZZ-Insilico hits fresh high on milestone payment from Menarini Group** Shares of biotech group InSilico Medicine Cayman TopCo 3696.HK jump 14% to HK$68.7, fresh high since December 30 debut** Stock on track for biggest daily gain since Jan 12; snapping 2-day decline** InSilico receives HK$39 mln  milestone payment from Menarini Group after first-in-patient dosing in Phase I trial of cancer drug MEN2501** Total licensing deal with Menarini's Stemline Therapeutics Inc exceeds $550 mln value** Stock has soared 186% from HK$24.05 IPO price in just over 3 weeks** YTD, stock is up 82.3%, Hang Seng Biotech Index .HSBIO up 5.3%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL1N3YZ036:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"1129443209","title":"INSILICO (03696) Receives HK$39 Million Milestone Payment from Menarini as Collaborative Project MEN2501 Administers First Dose to Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=1129443209","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129443209?lang=en_us&edition=fundamental","pubTime":"2026-02-03 08:10","pubTimestamp":1770077434,"startTime":"0","endTime":"0","summary":"INSILICO (03696) announced that the MEN2501 project, which it out-licensed to the Menarini Group, has achieved the first patient dosing in a Phase I clinical trial. According to the collaboration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2608195008","title":"Insilico Medicine erhält Meilensteinzahlung von Menarini nach Beginn der Phase-I-Studie mit MEN2501","url":"https://stock-news.laohu8.com/highlight/detail?id=2608195008","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608195008?lang=en_us&edition=fundamental","pubTime":"2026-02-03 08:01","pubTimestamp":1770076867,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL58Ldrs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"gpt_icon":0},{"id":"2608841598","title":"Insilico Medicine Rides ISM8969 Deals And AI Platform To Strong Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2608841598","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608841598?lang=en_us&edition=fundamental","pubTime":"2026-02-02 05:21","pubTimestamp":1769980860,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman TopCo (SEHK:3696) is pushing its ISM8969 NLRP3 inhibitor program forward through new co development deals, regulatory clearance and product progress.\nThe company has signed collaborations with Qilu Pharmaceutical and Hygtia Therapeutics around ISM8969 for central nervous system and inflammatory diseases, with global rights and large contract values attached.\nISM8969 has received US FDA clearance for a Phase I trial in healthy volunteers, targeting conditions that...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-rides-ism8969-deals-and-ai-platform-to-str","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3696/insilico-medicine-cayman-topco-shares/news/insilico-medicine-rides-ism8969-deals-and-ai-platform-to-str","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4528","BK4587","BK1141","BK4588","BK4585","BK4551","BK4023","BK4543","03696"],"gpt_icon":1}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":0.0593},{"period":"1month","weight":0.3431},{"period":"3month","weight":2.0437},{"period":"ytd","weight":0.9709}],"compareEarnings":[{"period":"1week","weight":0.0156},{"period":"1month","weight":0.0247},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.079},{"period":"1year","weight":0.2804},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"InSilico Medicine Cayman TopCo is a company principally engaged in the research and development of artificial intelligence in pharmaceuticals. The Company is engaged in the research and development of drug discovery engines. In addition, the Company is engaged in the copabdrug discovery and development of disease target identification, generation of novel molecules data, and predicting clinical trial outcomes.","exchange":"SEHK","name":"INSILICO","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INSILICO(03696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INSILICO,03696,INSILICO股票,INSILICO股票老虎,INSILICO股票老虎国际,INSILICO行情,INSILICO股票行情,INSILICO股价,INSILICO股市,INSILICO股票价格,INSILICO股票交易,INSILICO股票购买,INSILICO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INSILICO(03696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INSILICO(03696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}